Zhang, M., Wang, S., Wilffert, B., Tong, R., Soolingen, D., Hof, S., & Alffenaar, J. (2018). The association between the NAT2 genetic polymorphisms and risk of DILI during anti‐TB treatment: A systematic review and meta‐analysis. British journal of clinical pharmacology, 84(12), 2747-2760. https://doi.org/10.1111/bcp.13722
Chicago-Zitierstil (17. Ausg.)Zhang, Min, Shuqiang Wang, Bob Wilffert, Rongsheng Tong, Dick Soolingen, Susan Hof, und Jan‐Willem Alffenaar. "The Association Between the NAT2 Genetic Polymorphisms and Risk of DILI During Anti‐TB Treatment: A Systematic Review and Meta‐analysis." British Journal of Clinical Pharmacology 84, no. 12 (2018): 2747-2760. https://doi.org/10.1111/bcp.13722.
MLA-Zitierstil (9. Ausg.)Zhang, Min, et al. "The Association Between the NAT2 Genetic Polymorphisms and Risk of DILI During Anti‐TB Treatment: A Systematic Review and Meta‐analysis." British Journal of Clinical Pharmacology, vol. 84, no. 12, 2018, pp. 2747-2760, https://doi.org/10.1111/bcp.13722.